(Press-News.org) A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).
These antibodies, which target the viral protein A35, blocked viral spread in laboratory in vitro tests and, most importantly, protected rodents from severe disease and fully prevented death. The findings, published August 22 in Cell, also reveal that humans previously infected with mpox carry high levels of these protective antibodies in their blood, and that their presence is associated with milder symptoms and the absence of hospitalization.
Mpox is a viral disease caused by an orthopoxvirus (the family of viruses that causes smallpox, which killed more than 300 million people in the 20th century alone). This virus spreads mainly through close contact with an infected individual. The virus causes a painful rash, enlarged lymph nodes, and fever. It can make people very sick and leave scars.
A global outbreak of mpox began in 2022 and continues to this day. In the last three years, the World Health Organization twice declared the disease a public health emergency of international concern, yet effective treatment for this virus family is lacking. Recent human clinical trials for the leading candidate therapy did not show it to have efficacy. Thus, there is currently no approved drug to treat mpox. This study from Mount Sinai might change that.
“A previous study published in 2023 by our team showed that human antibodies targeting the viral protein A35 were unusually increased in sera in response to mpox infection compared with vaccination for smallpox or antibodies against other viral proteins,” said Camila Coelho, PhD, MBA, Assistant Professor of Microbiology at the Icahn School of Medicine and senior author of the paper. “Based on this earlier finding, we hypothesized that antibodies targeting A35 from mpox-infected individuals would be highly protective against orthopoxviruses, since the viruses in this family share high genetic similarity. We aimed to address the urgent unmet need for effective treatments for orthopoxviruses, and with the help of our outstanding collaborators, I am very proud to say that we are close to achieving that goal.”
The newly discovered antibodies bind to a region that is highly conserved across not only the orthopoxvirus genus, to which MPXV belongs to, but also the entire poxvirus family, which means the region is conserved among different viruses and is not prone to mutations or antibody escape. The ability of these antibodies to block viral spread, protect from severe disease, and fully prevent death suggests that they are promising drug candidates that could be tested in humans for the prevention or treatment of mpox. The antibodies have been patented by the Icahn School of Medicine at Mount Sinai.
“Ours is the first report of the crystal structure of a human antibody bound to an mpox virus protein, providing a detailed map of a vulnerability in the virus,” said Raianna Fantin, PhD, the postdoctoral researcher who is the first author of the study. “It is also the first time that monoclonal antibodies against orthopoxviruses were quantified in human sera. We were surprised by how consistently people recovering from mpox infection produced antibodies targeting the same A35 epitope of the virus as the antibodies we discovered.”
While the researchers see this as a promising next-generation therapy against mpox in humans, it is important to note that this is still in the research stage. Future testing in human clinical trials is needed to evaluate how the antibodies behave in the body, how long they last, where they go after being administered to the human body, and how well they prevent orthopoxvirus infection.
The research team plans to move the newly discovered antibodies into advanced preclinical safety and efficacy testing. Simultaneously, they are using the structural and immunological insights from the study to guide future work on understanding and enhancing the human immune response to mpox.
The study was conducted by the following laboratories from Mount Sinai’s Department of Microbiology: Coelho, Schotsaert, Simon, Bajic, and Krammer.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2025-2026.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.
###
END
Self-driving vehicles, drones, and robotic assistants are transforming industries including transportation, logistics, and health care. With new developments in hardware, AI, and machine learning, these autonomous agents can sense their surroundings with greater accuracy, understand complex environments, and engage in sophisticated reasoning.
But despite such advancements, deploying robots in dynamic, real-world settings—and getting them to do what we want—remains difficult.
“The overarching problem deals with robot capabilities,” says Cristian-Ioan Vasile, an assistant professor of mechanical engineering and mechanics in Lehigh University’s ...
ChatGPT and other generative AI models have achieved notable progress in natural language processing and generation, showing great potential in the medical field, such as automatically generating medical exam questions and answers, acting as personalized learning assistants, supporting course design, and aiding in medical imaging analysis. These models are also expected to be pivotal in training biosafety laboratory researchers by providing interactive learning experiences.
In this study, a dataset of 62 text-based and 8 image-based biosafety questions was collected ...
A special set of neurons directs mice’s attention to or away from their peers, depending on the situation. The Kobe University discovery has implications for finding causes for neuropsychiatric conditions such as autism spectrum disorder or schizophrenia.
Social interactions abound with decisions: How much time do we spend with a friend? Do we prioritize time with a friend who looks distressed? Like for all behavior, there are specialized clusters of neurons in the brain that are responsible for fine-tuning such complex behavior, and it is known that developmental defects in these areas are related ...
Summertime is beer time – even if the consumption of alcoholic beers is declining in Switzerland. And for beer lovers, there is nothing better than a head of foam topping the golden, sparkling barley juice. But with many beers, the dream is quickly shattered, and the foam collapses before you can take your first sip. There are also types of beer, however, where the head lasts a long time.
ETH researchers led by Jan Vermant, Professor of Soft Materials, have now discovered just why this is the case. Their study has just been published in the journal Physics of Fluids. The ...
WASHINGTON, August 26, 2025 – Beer is one of the world’s most popular drinks, and one of the clearest signs of a good brew is a big head of foam at the top of a poured glass. Even brewers will use the quality of foam as an indicator of a beer having completed the fermentation process. However, despite its importance, what makes a large, stable foam is not entirely understood.
In Physics of Fluids, from AIP Publishing, researchers from ETH Zurich and Eindhoven University of Technology investigated the stability of beer foams, examining multiple types of beer at different stages of the fermentation process.
Like ...
Older adults who are overweight may face a lower risk of death in the first 30 days following major elective surgery compared with those who have a normal body mass index (BMI), new research suggests.
The study, to be published August 26 in the peer-reviewed JAMA Network Open, examined outcomes in older surgical patients and found that being overweight (BMI 25–29.9) was associated with the lowest short-term mortality rates. In contrast, normal and underweight patients had significantly higher risk ...
About The Study: In this cross-sectional study of preadolescent children, greater lean mass and higher fitness were associated with fewer anxiety and depression symptoms, while higher visceral adipose tissue was associated with increased symptoms of both. Body fat percentage was only associated with greater anxiety. These findings highlight the roles of body composition in mental health and underscore the value of early identification of physical health markers to support children’s well-being and development.
Corresponding author: To contact the corresponding author, Lauren B. Raine, M.P.H., Ph.D., email l.raine@northeastern.edu.
To ...
About The Study: In this study, underrepresented in medicine (URiM) student matriculation into U.S. medical schools declined after the 2023 Supreme Court of the United States (SCOTUS) ruling, with an emergent disparity in acceptance rates of URiM applicants relative to Asian and white students. The decline in URiM student matriculation was concentrated in states without a preexisting state-level affirmative action ban, suggesting that there may be an association between the SCOTUS ruling and demographic ...
Ghent, 26 August 2025 – Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are key immune messengers that help kick-start the body’s defenses, show specific responses to lipid nanoparticles. These findings, published in Cell Reports, could lead to safer and more effective vaccines.
Dendritic cells and lipid nanoparticles
Dendritic cells are among the first to detect viruses, bacteria, or other immune challenges. These cells help coordinate the immune system’s response by alerting T cells, the immune system’s soldiers trained to eliminate threats. But dendritic cells ...
A NIMS research team has discovered a unique phenomenon that the fatigue limit of steel is improved by prior cyclic deformation (fatigue) training. Based on this finding, the research team developed a novel “pre-fatigue training” technique, which successfully doubled the fatigue limit of high-strength steel by suppressing crack initiation. This strategy offers a versatile approach to improving fatigue limit in general steels, providing an effective alternative to tempering heat treatment that inevitably sacrifices tensile strength. ...
